Mark J. Newman, PhD Presentation: “Vaccine design to address the immunocompromised: T-lymphocyte driven…Balanced immunity - Broader specificity – Increased memory.” Kelly T. McKee, Jr., MD, MPH Presentation: “Interim Safety and Reactogenicity of GEO-CM04S1, an MVA-vectored, multi-antigen COVID-19 vaccine, in adults with hematologic malignancies receiving cellular therapies.”
Monday, October 13, 2025 - Thursday, October 16, 2025
Amsterdam, Netherlands
Mark J. Newman, PhD Presentation: “Vaccine design to address the immunocompromised: T-lymphocyte driven…Balanced immunity - Broader specificity – Increased memory.” Kelly T. McKee, Jr., MD, MPH Presentation: “Interim Safety and Reactogenicity of GEO-CM04S1, an MVA-vectored, multi-antigen COVID-19 vaccine, in adults with hematologic malignancies receiving cellular therapies.”
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →World Vaccine Congress Europe 2025 takes place on Monday, October 13, 2025 to Thursday, October 16, 2025.
World Vaccine Congress Europe 2025 is held in Amsterdam, Netherlands.
Pricing information is available on the event website.
World Vaccine Congress Europe 2025 is designed for technology professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox